Urinary incontinence and pelvic organ prolapse in women: management

You can now review and comment on this draft guideline.

The consultation closes on 19 November 2018 at 5pm

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline
• Evidence reviews
  • Evidence review A – Urodynamic assessment prior to primary surgery for stress urinary incontinence
  • Evidence review B– Treatment options for women using absorbent containment products
  • Evidence review C – Risks to cognitive function for women taking anticholinergic drugs for overactive bladder
  • Evidence review D– Management of overactive bladder
  • Evidence review E – Surgical and conservative management of stress urinary incontinence
  • Evidence review F – Effectiveness of multidisciplinary teams for the assessment and management of urinary incontinence or pelvic organ prolapse
  • Evidence review G – Assessing pelvic organ prolapse
  • Evidence review H – Lifestyle and conservative management options for pelvic organ prolapse
  • Evidence review I– Surgical management of pelvic organ prolapse
  • Evidence review J– Surgical management of pelvic organ prolapse and stress urinary incontinence
  • Evidence review K– Assessing mesh complications after pelvic floor mesh surgery
  • Evidence review L – Management of mesh complications

• Supplementary materials
  • Supplementary material A- Staff list
  • Supplementary material B - Glossary and abbreviations
  • Supplementary material C - Methods
  • Supplementary material D – health economics literature

• Economic model

If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee membership list
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: UIwomen@nice.nhs.uk

Deadline: 5pm on 19 November 2018

5. Economic model

The developer has produced an economic model to support the guideline on Urinary incontinence (update) and pelvic organ prolapse in women: management.  To receive an executable version of this model, please submit a request to UIwomen@nice.nhs.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 5pm on 19 November 2018.